Clinical trials

EMN-COVID

04/10/2020

COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS: AN EUROPEAN PROSPECTIVE AND RETROSPECTIVE OBSERVATIONAL STUDY

The aim of this proposal is to deliver a pan-European observational study collecting data on patient outcomes with COVID19, collecting data retrospectively for those who have already been infected, and prospectively.

OBJECTIVES:

The aim of the datasets to be collected will be:

To characterize the nature of COVID19 in MM patients (duration, health resource needs)
To define the severity of disease, outcomes and any association with Systemic anti-cancer therapy (SACT)
To define laboratory values associated with the disease incidence and outcomes.
To define myeloma patient subgroups where the disease has a greater representation, and whether there are differences in outcomes
To define the role of frailty (calculated using mIMWG frailty score) in delineating those at greater risk
To define if the variation in government/social strategies have had an association with outcomes utilizing inter-country datasets

PATIENTS: Multiple myeloma patients infected by (SARS-CoV-2)

SAMPLE SIZE: 1000